scPharmaceuticals Inc. Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Scpharmaceuticals Inc. |
| Form Type | 10-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
SCPH filed its 2024 10-K. Full financials and biz details inside.
AI Summary
scPharmaceuticals Inc. filed its 2024 10-K on March 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, located at 25 Burlington Mall Road, Suite 203, Burlington, MA, operates in the pharmaceutical preparations industry. Key financial details and business operations for the period are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of scPharmaceuticals Inc.'s financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, scPharmaceuticals Inc. faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 001-38293 — SEC File Number (Identifies the company's filing with the SEC.)
- 0000950170-25-042159 — Accession Number (Unique identifier for this specific SEC filing.)
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations.)
Key Players & Entities
- scPharmaceuticals Inc. (company) — Filer of the 10-K
- 25 Burlington Mall Road, Suite 203, Burlington, MA (company) — Business and Mail Address
- 20241231 (date) — Fiscal Year End
- 20250319 (date) — Filing Date
- Cowen and Company LLC (company) — Mentioned in relation to an ATM agreement
FAQ
What was scPharmaceuticals Inc.'s revenue from contracts with customers in the fiscal year 2023?
The filing indicates that scPharmaceuticals Inc. recognized revenue from contracts with customers, with specific details for 2023 available within the full report.
When did scPharmaceuticals Inc. enter into the Twenty Twenty-One ATM Agreement?
The Twenty Twenty-One ATM Agreement was entered into on March 23, 2021.
What is the state of incorporation for scPharmaceuticals Inc.?
scPharmaceuticals Inc. is incorporated in Delaware (DE).
Who is identified as 'CustomerTwo' in the context of customer concentration risk?
The filing mentions 'CustomerTwo' in relation to 'us-gaap:CustomerConcentrationRiskMember', indicating a significant customer, but specific details are within the full report.
What is the primary business of scPharmaceuticals Inc. according to its SIC code?
The company's SIC code of 2834 indicates its primary business is in Pharmaceutical Preparations.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 19, 2025 regarding scPharmaceuticals Inc..